Ralph Kauten

Nov 01, 2014

Lucigen this week named Ralph Kauten as CEO. Kauten has been a member of Lucigen's board for the past 10 years and has served as chairman for the last four. Kauten was previously involved in the start up and management of life science companies Promega, PanVera (acquired by Aurora Biosciences) and Mirus Bio (acquired by Roche Pharmaceuticals).

David Mead, who founded Lucigen and has served as CEO from the company's inception in 1998, will remain with the company as CSO.